Thank you for donating!
You can donate using the following services.
Donate Today
Search
Need support today?
Email: info@npuk.org
Helpline: 0191 415 0693
Main menu
Niemann-Pick Diseases
About Us
Care & Support
Research
Fundraising
Resources
Blog
News
NPUK Shop
COVID-19
News
NPUK
>
News
21.10.20
Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment per US FDA
Read more
19.10.20
IntraBio Reports Further Detail on Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C
Read more
19.10.20
"Illustrate your Imagination" (Orphazyme)
Read more
30.09.20
IntraBio Reports Positive Data from IB1001 Multinational Clinical Trial for the Treatment of Niemann-Pick disease Type C
Read more
16.09.20
Orphazyme announces U.S. FDA acceptance and Priority Review of New Drug Application for arimoclomol for Niemann-Pick disease Type C
Read more
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Next
Clinical Trials
CTD Holdings Inc
IntraBio
News
NPUK Annual Family Conference
NPUK News
Orphazyme
Sanofi Genzyme
The Quinn Madeline Foundation
Uncategorized
Donate today
Follow NPUK
Contact us
Donate today
Email: info@npuk.org
Helpline: 0191 415 0693